A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
Titel:
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)
Auteur:
Maluf, Fernando C. Schutz, Fabio A. Cronemberger, Eduardo H. Luz, Murilo de A. Martins, Suelen P.S. Muniz, David Q.B. Bastos, Diogo A. Cárcano, Flavio M. Smaletz, Oren Soares, Andrey Peixoto, Fábio A. Gomes, Andrea J. Cruz, Felipe M. Franke, Fabio A. Herchenhorn, Daniel dos Santos, Telma M. Fabricio, Vanessa de C. Gidekel, Rosemarie Werutsky, Gustavo de Jesus, Rafaela G. Souza, Vinicius C. Fay, André P.